recorded export sales of 270.50 million Baht which decrease from the same quarter last year totaling 32.36 million Baht or 10.68% (Export sales in the third quarter of 2018 was 302.86 million Baht). Cost of

4477 2019 0202 latoT 34340 34303 latoT caooTt d o c oseaot ToToT 472.09 495.44 Cost of Sales for Q1 / 2020 and Q1 / 2019 was 376.05 million baht and 397.41 million baht, respectively. It decreased 21.36

million baht or 14.61% due to a decrease in interest income. 2. Cost of goods sold and services of the Company’s group total of 53.06 million baht, a decrease of 16.71 million baht or 23.95%, details are as

. Distribution cost decreased by Baht 1.43 million resulting from expenditures control of the Company. 4. Financial cost decreased by Baht 3.79 million resulting from decreased in loan amount. 5. In same period of

executives of the company under Chapter 3/1 of the Securities and Exchange Act B.E. 2535. The proposed rules aim to achieve a better balance between compliance cost for listed firms and benefit of public

% Revenue from social security 197.53 164.68 20% Revenue from Hospital Operations 445.88 382.92 16% Cost of hospital operations 285.42 257.36 11% Gross margin 160.45 125.57 28% % Gross margin 36% 33% 3

. The Company and subsidiaries had cost of sales and services in the amount of THB 627 million which decreased by THB 389 million or decreased by 38.2 percent from the same period last year due to the

- region listed companies. At the global level, the SEC facilitated the opportunity for Thai intermediaries to sell the products in renowned markets; China, Japan and Korea, for example, while the

on intra- region listed companies. At the global level, the SEC facilitated the opportunity for Thai intermediaries to sell the products in renowned markets; China, Japan and Korea, for example, while

801 106 13% Cost of sales and services -789 -621 168 27% -682 -608 74 12% Gross Profit 248 235 13 5% 225 193 32 16% Other Income 5 0 5 1,701% 14 7 7 117% Selling expense -81 -70 11 16% -71 -61 10 17